Cargando…
Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course
Analysis of liver biopsy specimens showed that SARS-CoV-2 might have led to liver damage. This study aimed to evaluate the role of selected hepatokines and myokines in the development and progression of COVID-19. Seventy patients with laboratory-confirmed COVID-19 and 20 healthy volunteers were enro...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533535/ https://www.ncbi.nlm.nih.gov/pubmed/34680053 http://dx.doi.org/10.3390/biom11101422 |
_version_ | 1784587337089417216 |
---|---|
author | Kukla, Michał Menżyk, Tomasz Dembiński, Marcin Winiarski, Marek Garlicki, Aleksander Bociąga-Jasik, Monika Skonieczna, Magdalena Hudy, Dorota Maziarz, Barbara Kuśnierz-Cabala, Beata Kapusta, Maria Skladany, Lubomir Grgurevic, Ivica Mikolasevic, Ivana Filipec-Kanizaj, Tajana Wójcik-Bugajska, Małgorzata Grodzicki, Tomasz Rogula, Tomasz Stygar, Dominika |
author_facet | Kukla, Michał Menżyk, Tomasz Dembiński, Marcin Winiarski, Marek Garlicki, Aleksander Bociąga-Jasik, Monika Skonieczna, Magdalena Hudy, Dorota Maziarz, Barbara Kuśnierz-Cabala, Beata Kapusta, Maria Skladany, Lubomir Grgurevic, Ivica Mikolasevic, Ivana Filipec-Kanizaj, Tajana Wójcik-Bugajska, Małgorzata Grodzicki, Tomasz Rogula, Tomasz Stygar, Dominika |
author_sort | Kukla, Michał |
collection | PubMed |
description | Analysis of liver biopsy specimens showed that SARS-CoV-2 might have led to liver damage. This study aimed to evaluate the role of selected hepatokines and myokines in the development and progression of COVID-19. Seventy patients with laboratory-confirmed COVID-19 and 20 healthy volunteers were enrolled in the study. Irisin, pentraxin 3, fetuin-A, and FGF-21 serum concentrations and biochemical parameters were assessed using an immunoenzymatic method with commercially available enzyme immunoassay (EIA) or enzyme-linked immunosorbent assay (ELISA) kits. Serum fetuin-A concentrations were significantly decreased in COVID-19 patients compared to healthy volunteers. The serum concentration of FGF-21 was significantly increased in obese COVID-19 patients compared to overweight ones. Moreover, the FGF-21 level was higher in COVID-19 patients diagnosed with metabolic syndrome than in patients without metabolic syndrome. PTX3 concentration was higher in COVID-19 patients with higher HOMA-IR values than those with lower HOMA-IR values. COVID-19 patients with HOMA-IR ≤ 3 and >3 had significantly lower fetuin-A levels than the control group. Irisin concentration was significantly decreased in the HOMA-IR ≤ 3 COVID-19 subgroup when comparing with the control group. Lower levels of fetuin-A observed in COVID-19 patients despite higher HOMA-IR, CRP, and ferritin levels, pneumonia, patients requiring ICU care suggests that fetuin-A deficiency predisposes to more severe COVID-19 course. Upregulated pentraxin 3 may be used as a potential predictor of COVID-19 severity. |
format | Online Article Text |
id | pubmed-8533535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85335352021-10-23 Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course Kukla, Michał Menżyk, Tomasz Dembiński, Marcin Winiarski, Marek Garlicki, Aleksander Bociąga-Jasik, Monika Skonieczna, Magdalena Hudy, Dorota Maziarz, Barbara Kuśnierz-Cabala, Beata Kapusta, Maria Skladany, Lubomir Grgurevic, Ivica Mikolasevic, Ivana Filipec-Kanizaj, Tajana Wójcik-Bugajska, Małgorzata Grodzicki, Tomasz Rogula, Tomasz Stygar, Dominika Biomolecules Article Analysis of liver biopsy specimens showed that SARS-CoV-2 might have led to liver damage. This study aimed to evaluate the role of selected hepatokines and myokines in the development and progression of COVID-19. Seventy patients with laboratory-confirmed COVID-19 and 20 healthy volunteers were enrolled in the study. Irisin, pentraxin 3, fetuin-A, and FGF-21 serum concentrations and biochemical parameters were assessed using an immunoenzymatic method with commercially available enzyme immunoassay (EIA) or enzyme-linked immunosorbent assay (ELISA) kits. Serum fetuin-A concentrations were significantly decreased in COVID-19 patients compared to healthy volunteers. The serum concentration of FGF-21 was significantly increased in obese COVID-19 patients compared to overweight ones. Moreover, the FGF-21 level was higher in COVID-19 patients diagnosed with metabolic syndrome than in patients without metabolic syndrome. PTX3 concentration was higher in COVID-19 patients with higher HOMA-IR values than those with lower HOMA-IR values. COVID-19 patients with HOMA-IR ≤ 3 and >3 had significantly lower fetuin-A levels than the control group. Irisin concentration was significantly decreased in the HOMA-IR ≤ 3 COVID-19 subgroup when comparing with the control group. Lower levels of fetuin-A observed in COVID-19 patients despite higher HOMA-IR, CRP, and ferritin levels, pneumonia, patients requiring ICU care suggests that fetuin-A deficiency predisposes to more severe COVID-19 course. Upregulated pentraxin 3 may be used as a potential predictor of COVID-19 severity. MDPI 2021-09-28 /pmc/articles/PMC8533535/ /pubmed/34680053 http://dx.doi.org/10.3390/biom11101422 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kukla, Michał Menżyk, Tomasz Dembiński, Marcin Winiarski, Marek Garlicki, Aleksander Bociąga-Jasik, Monika Skonieczna, Magdalena Hudy, Dorota Maziarz, Barbara Kuśnierz-Cabala, Beata Kapusta, Maria Skladany, Lubomir Grgurevic, Ivica Mikolasevic, Ivana Filipec-Kanizaj, Tajana Wójcik-Bugajska, Małgorzata Grodzicki, Tomasz Rogula, Tomasz Stygar, Dominika Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course |
title | Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course |
title_full | Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course |
title_fullStr | Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course |
title_full_unstemmed | Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course |
title_short | Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course |
title_sort | fetuin-a deficiency but not pentraxin 3, fgf-21, or irisin, predisposes to more serious covid-19 course |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533535/ https://www.ncbi.nlm.nih.gov/pubmed/34680053 http://dx.doi.org/10.3390/biom11101422 |
work_keys_str_mv | AT kuklamichał fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT menzyktomasz fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT dembinskimarcin fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT winiarskimarek fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT garlickialeksander fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT bociagajasikmonika fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT skoniecznamagdalena fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT hudydorota fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT maziarzbarbara fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT kusnierzcabalabeata fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT kapustamaria fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT skladanylubomir fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT grgurevicivica fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT mikolasevicivana fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT filipeckanizajtajana fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT wojcikbugajskamałgorzata fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT grodzickitomasz fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT rogulatomasz fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course AT stygardominika fetuinadeficiencybutnotpentraxin3fgf21oririsinpredisposestomoreseriouscovid19course |